Cancer Immunotherapy Remains Hot as Aduro Biotech Doubles In Value On IPO Debut - (TheStreet via NewsPoints Desk)

  • Shares in Aduro Biotech more than doubled after the company priced its initial public offering (IPO), TheStreet reported Wednesday.
  • Earlier this week, the company unveiled plans to raise $119 million by offering 7 million shares at $17 per share.
  • Following the jump in share price following the IPO, Aduro has a current market value of $2 billion.

To read more NewsPoints articles, click here.